Anti-Demodex wipes development

I-MED制药公司(i-MED)为全球验光和眼科社区护理部门提供创新的眼表疾病(OSD)解决方案。专注于研究，I-MED Pharma的愿景是成为世界领先的干眼症和OSD公司。目前，他们提供全套OSD产品，包括诊断工具、人造泪水、眼卫生清洁剂和治疗附件。蠕形螨会导致干眼病和其他疾病，可以使用一些天然产品将其保持在无害的水平。然而，目前的产品已被证明在体外对眼腺有潜在的有害影响。I-MED Pharma将与Seneca的生物科学和应用化学学院合作，开发一种含有有效成分的眼巾配方，该配方可在不刺激眼睛和眼生理的情况下限制蠕形螨的扩散。在Sonal Kamath教授和Sharon Robertson教授的带领下，Seneca化妆品科学研究生证书项目的学生研究助理(RAS)将应用他们的学术知识和技能，同时在配方和评估产品功效方面积累实践经验，创建一种无TTO湿巾的原型配方，旨在有效地对抗蠕形螨，不会对眼睛造成刺激。这一新配方将巩固i-MED作为干眼护理和眼部卫生领域的领导者在全球市场的地位。

I-MED Pharma Inc. (I-MED) provides innovative ocular surface disease (OSD) solutions to the globaloptometry and ophthalmology community-based care sectors. With a focus on research, I-MED Pharma'svision is to be the leading dry eye and OSD company in the world. Currently, they offer a complete range ofOSD products, including diagnostic tools, artificial tears, ocular hygiene cleansers, and therapeutic accessories.The Demodex mite, which can cause Dry Eye Disease and other ailments, can be maintained at a harmlesslevel using some natural products. However, current products have been shown in vitro to have potentiallyharmful effects on eye glands. I-MED Pharma will collaborate with Seneca's School of Biological Sciences andApplied Chemistry to develop an eye wipe formulation with an active ingredient that limits proliferation ofDemodex mites without irritating the eye and eye-physiology. Led by Professors Sonal Kamath and SharonRobertson, student Research Assistants (RAs) from Seneca's Cosmetic Sciences Graduate Certificate programwill apply their academic knowledge and skills, while developing practical experience in formulation andevaluating product efficacy, to create a prototype formulation of a TTO-free wipe designed to be effectiveagainst Demodex mites that does not cause irritation to the eye. This new formulation will reinforce I-MED'sposition in the global market as a leader in dry eye care and eye hygiene.